Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article
贝伐单抗经渗透性血脑屏障破坏后超选择性动脉内脑灌注治疗复发性恶性胶质瘤的安全性和最大耐受剂量。临床文章
期刊:Journal of Neurosurgery
影响因子:3.6
doi:10.3171/2010.9.JNS101223
Boockvar, John A; Tsiouris, Apostolos J; Hofstetter, Christoph P; Kovanlikaya, Ilhami; Fralin, Sherese; Kesavabhotla, Kartik; Seedial, Stephen M; Pannullo, Susan C; Schwartz, Theodore H; Stieg, Philip; Zimmerman, Robert D; Knopman, Jared; Scheff, Ronald J; Christos, Paul; Vallabhajosula, Shankar; Riina, Howard A
